Rutgers Cancer Institute of New Jersey Associate Chief of Urology and Urologic Oncology and Director of the Kidney Cancer Program Eric A. Singer, MD, MA, MS, FACS, has been named a Fellow of the American Society of Clinical Oncology (FASCO). This distinction honors members for their extraordinary volunteer service and dedication to the American Society of Clinical Oncology (ASCO).
The American Society of Hematology (ASH), is the world’s largest professional society with a focus on the causes and treatment of blood disorders. Experts from Rutgers Cancer Institute of New Jersey will be presenting a variety of key hematology data at the 62nd American Society of Hematology Annual Meeting. This includes 22 scheduled presentations, including 10 oral presentations examining several types of blood cancers including leukemia, lymphoma, and myeloma.
New Brunswick, N.J., November 6, 2020 – Al Roker, longtime television personality and current weather anchor on NBC’s Today Show, announced today that he has been diagnosed with prostate cancer. Prostate cancer is marked by an uncontrolled growth of cells in…
Is breastfeeding safe and possible for mothers who have a history of breast cancer? Investigators at Rutgers Cancer Institute of New Jersey recently explored this question by conducting a systematic review on the feasibility and challenges of breastfeeding among breast cancer survivors of reproductive age.
While researchers continue to make advances in breast cancer detection and treatment, one of the best ways to tackle the disease is through early detection and screening. Rutgers Cancer Institute expert shares more about risk factors, warning signs, and screening.
Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, welcomes a new leader to its team of internationally recognized physicians, researchers and administrators.
Researchers from Rutgers Cancer Institute of New Jersey along with collaborators from Princeton University identify a new drug that has therapeutic effect against the aggressive hematological disease T-cell acute lymphoblastic leukemia.
New Brunswick, NJ – The Rutgers School of Public Health is excited to announce that Stephanie Shiau, PhD, will be joining the department of biostatistics and epidemiology as an instructor in August. Shiau’s research focuses on the effects of human immunodeficiency virus (HIV)…